United States Valley Fever Market Set for Strong Growth as Rising Awareness and Advanced Diagnostics Drive Demand 2025 | Top key players - Pfizer, Merck, Astellas Pharma

Market Size and Growth:

The Global Valley Fever Market size reached US$ 1.03 Billion with rise of US$ 1.10 Billion in 2024 is expected to reach US$ 1.98 Billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

The Valley Fever Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Valley Fever market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/valley-fever-market?sz

The Valley Fever Market refers to the healthcare segment focused on diagnosing, treating, and managing coccidioidomycosis, a fungal infection caused by inhaling spores of Coccidioides species. It includes antifungal therapies, diagnostic tools, vaccines under research, and supportive care. Market growth is driven by rising prevalence in endemic regions, improved diagnostics, and ongoing advancements in therapeutic development.

Recent Key Developments of United States (U.S):

Record-High Case Numbers: The number of Valley Fever cases continued to rise in 2025, following a record year in 2024. The California Department of Public Health (CDPH) reported over 6,700 cases by the end of July 2025, and predicted the year's total would surpass the 2024 record of nearly 12,500 cases.

Increased Public Health Awareness: In August 2025, during Valley Fever Awareness Month, the CDPH issued a public health alert urging residents, visitors, and healthcare providers in endemic regions like California's Central Valley to be vigilant for symptoms. This campaign aims to improve early detection and treatment.

Market Growth and Investment: The Valley Fever treatment market is experiencing robust growth, with a projected market size of approximately $550 million in 2025. This growth is driven by rising case numbers, increased awareness, and ongoing research and development into new treatments and diagnostics.

Ongoing Research and Clinical Trials: Research efforts continue to focus on understanding the immune response to Valley Fever and developing new treatments. Clinical trials, like the one sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), are still being conducted to evaluate the effectiveness of existing drugs like fluconazole for early treatment.

Focus on Prevention: With the increase in cases, there is a continued emphasis on prevention strategies. Public health warnings and guidance for at-risk groups, such as outdoor workers, highlight the importance of wearing N95 masks in dusty environments and minimizing soil disturbance to reduce the inhalation of fungal spores.

Key Players:

Pfizer
Janssen (Johnson & Johnson)
Merck
Astellas Pharma.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=valley-fever-market

Market Segmentation:

By Type of Infection: Acute Valley Fever, Chronic Valley Fever.

By Drug Type: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Amphotericin B (liposomal / conventional).

By Route of Administration: Oral, Intravenous (IV infusion).

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/valley-fever-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Valley Fever market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Valley Fever Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Valley Fever market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Valley Fever Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Valley Fever Market in 2025?
◆ What is the projected growth rate of the Valley Fever Market through 2033?
◆ Who are the key players in the Valley Fever Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.